HCC827/STAT5 Reporter (GFP) stable cell line

HCC827/STAT5 Reporter (GFP) cells are derived from the human lung adenocarcinoma HCC827 cell line by stably integration of a STAT5 GFP reporter construct. HCC827 cells are widely used in cancer research, particularly in studies related to lung cancer biology and drug discovery. HCC827 cells carry a mutation in the epidermal growth factor receptor (EGFR) gene, which results in constitutive activation of the EGFR signaling pathway, have been used as a model system to study the mechanisms of EGFR tyrosine kinase inhibitors (TKIs) and to evaluate the efficacy of these drugs in preclinical studies. HCC827 /STAT5 Reporter (GFP) cells stably express GFP under the control of the STAT5 response elements, can be used for monitoring the activity of STAT5 signaling pathway.